Jane Street’s ESSA Pharma EPIX Stock Holding History

Jane Street’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-43,907	Closed	-$52.6K	–	10985
2025 Q2	$74.6K	Buy	+43,907	New	+$74.1K	﹤0.01%	9070
2025 Q1	–	Sell	-45,810	Closed	-$82K	–	9696
2024 Q4	$82K	Buy	+45,810	New	+$146K	﹤0.01%	8831
2022 Q3	–	Sell	-40,421	Closed	-$127K	–	9867
2022 Q2	$127K	Buy	40,421 +15,548	+63%	+$86.9K	﹤0.01%	8511
2022 Q1	$154K	Buy	+24,873	New	+$219K	﹤0.01%	9209
2021 Q2	–	Sell	-29,449	Closed	-$855K	–	9913
2021 Q1	$855K	Buy	+29,449	New	+$685K	﹤0.01%	5756

Jane Street's EPIX Position: Q3 2025 in Review

Jane Street sold out of ESSA Pharma (EPIX) in Q3 2025, closing a stake of 43,907 shares — an estimated $52.6K sold.

Jane Street first reported a position in EPIX in Q1 2021 and held it in 5 quarters. The position peaked at $855K in Q1 2021. 32 funds tracked by Wall St. Rank hold EPIX as of Q3 2025.

Jane Street reported no remaining ESSA Pharma position as of Q3 2025 after selling out during the quarter.
Jane Street sold 43,907 ESSA Pharma shares in Q3 2025, an estimated $52.6K.
Jane Street first reported a position in ESSA Pharma in Q1 2021 and held it in 5 quarters.
Jane Street's ESSA Pharma position peaked at $855K in Q1 2021.
32 funds tracked by Wall St. Rank held ESSA Pharma as of Q3 2025.

Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.